128 related articles for article (PubMed ID: 4374226)
1. Cell mediated immunity to herpesvirus type 1 in carcinoma and pre-cancerous lesions.
Lehner T; Shillitoe EJ; Wilton JM; Ivanyi L
Br J Cancer Suppl; 1973 Aug; 1():128-34. PubMed ID: 4374226
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity and antibodies to Herpesvirus hominis type 1 in oral leukoplakia and carcinoma.
Lehner T; Wilton JM; Shillitoe EJ; Ivanyi L
Br J Cancer; 1973 May; 27(5):351-61. PubMed ID: 4351511
[TBL] [Abstract][Full Text] [Related]
3. Immunopathology of oral leukoplakia.
Lehner T
Br J Cancer; 1970 Sep; 24(3):442-6. PubMed ID: 4319938
[TBL] [Abstract][Full Text] [Related]
4. Epithelial isoantigens A, B and H in oral carcinomas.
Gupta YN; Gupta S; Singh IJ; Khanna NN; Agarwal MK
Ear Nose Throat J; 1985 May; 64(5):239-42. PubMed ID: 3996275
[No Abstract] [Full Text] [Related]
5. Cell-mediated immunity to herpes simplex virus types 1 and 2 antigens in leukoplakia and carcinoma in man.
Shillitoe EJ; Tarro G; Lehner T
Oncology; 1976; 33(4):192-5. PubMed ID: 65753
[TBL] [Abstract][Full Text] [Related]
6. [Study of testicular cancer gene expression in samples of oral leukoplakia and squamous cell carcinoma of the mouth].
Skorodumova LO; Muraev AA; Zakharova ES; Shepelev MV; Korobko IV; Zaderenko IA; Ivanov SIu; Gnuchev NV; Georgiev GP; Larin SS
Vopr Onkol; 2012; 58(4):486-92. PubMed ID: 23607202
[TBL] [Abstract][Full Text] [Related]
7. MAGE-A antigens in lesions of the oral mucosa.
Krauss E; Rauthe S; Gattenlöhner S; Reuther T; Kochel M; Kriegebaum U; Kübler AC; Müller-Richter UD
Clin Oral Investig; 2011 Jun; 15(3):315-20. PubMed ID: 20174843
[TBL] [Abstract][Full Text] [Related]
8. [The significance of immunologic parameters for preoperative prognostication in carcinoma of the mouth].
Hyckel P; Metzner G; Müller P; Haroske D; Quade R
Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(6):461-8. PubMed ID: 3869490
[No Abstract] [Full Text] [Related]
9. Immunological abnormalities in oral carcinoma and oral keratosis.
Scully C
J Maxillofac Surg; 1982 May; 10(2):113-5. PubMed ID: 6954222
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immune responses in oral disease: a review.
Lehner T
J Oral Pathol; 1972; 1(1):39-58. PubMed ID: 4626994
[No Abstract] [Full Text] [Related]
11. Immunology of premalignant and malignant conditions of the oral cavity. II. Circulating immune complexes.
Balaram P; Pillai MR; Abraham T
J Oral Pathol; 1987 Sep; 16(8):389-91. PubMed ID: 3121822
[TBL] [Abstract][Full Text] [Related]
12. Changes in peripheral blood lymphocyte phenotypes distribution in patients with oral cancer/oral leukoplakia in Taiwan.
Lee JJ; Lin CL; Chen TH; Kok SH; Chang MC; Jeng JH
Int J Oral Maxillofac Surg; 2010 Aug; 39(8):806-14. PubMed ID: 20605406
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells and T cells sense cell dysplasia in oral leukoplakias and oral squamous cell carcinomas--evidence for immunosurveillance.
Öhman J; Magnusson B; Telemo E; Jontell M; Hasséus B
Scand J Immunol; 2012 Jul; 76(1):39-48. PubMed ID: 22469080
[TBL] [Abstract][Full Text] [Related]
14. The role of immunology in the diagnosis, prognosis and treatment planning of oral cancer.
Shillitoe EJ
Proc R Soc Med; 1976 Oct; 69(10):747-9. PubMed ID: 186794
[No Abstract] [Full Text] [Related]
15. Letter: Cell mediated response to herpes simplex virion and non-virion antigens in patients with cervical carcinoma with a depressed response to phytohemagglutinin.
Sprecher-Golberger S; Thiry L; de Halleux F; Bossens M; Gould I
Biomedicine; 1975 Nov; 23(9):399-401. PubMed ID: 182294
[No Abstract] [Full Text] [Related]
16. [Effect of therapeutic measures in carcinoma of the mouth on the immunologic response capacity of those patients].
Hyckel P; Metzner G; Haroske D; Müller P
Dtsch Z Mund Kiefer Gesichtschir; 1985; 9(6):469-74. PubMed ID: 3869491
[No Abstract] [Full Text] [Related]
17. Cell-mediated immunity to human oral carcinoma, and cross reactivity to patients with oral leukoplakia demonstrated by the leukocyte migration test.
Roed-Petersen B
Allergy; 1982 Aug; 37(6):429-35. PubMed ID: 7137537
[TBL] [Abstract][Full Text] [Related]
18. ABH isoantigens in cancer of oral tissues.
Sukreeyapong Y; Chiewsilp P; Bhamarapravati N
J Med Assoc Thai; 1976 Jan; 59(1):12-5. PubMed ID: 1249509
[No Abstract] [Full Text] [Related]
19. [Oral cancer and precancer. Ultrastructural and immunopathologic aspects (author's transl)].
Burkhardt A
Veroff Pathol; 1980; 112():1-271. PubMed ID: 7210891
[No Abstract] [Full Text] [Related]
20. Evaluation of the Ca 1 monoclonal antibody in distinguishing oral squamous cell carcinoma from non-malignant or premalignant oral lesions.
Masouredis CM; Green TL; Greenspan JS
J Oral Pathol; 1987 Jul; 16(6):307-9. PubMed ID: 3119804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
